# PERT in Acute Necrotizing Pancreatitis

> **NCT07211568** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Asian Institute of Gastroenterology, India** · enrollment: 188 (estimated)

## Conditions studied

- Acute Pancreatitis Necrotizing
- Nutrition Assessment

## Interventions

- **DRUG:** Pancreatic Enzyme Replacement Therapy
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07211568
- **Lead sponsor:** Asian Institute of Gastroenterology, India
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2027-04-30
- **Final completion:** 2027-07-31
- **Target enrollment:** 188 (ESTIMATED)
- **Last updated:** 2025-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07211568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07211568, "PERT in Acute Necrotizing Pancreatitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07211568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*